MD Anderson Cancer Cente
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
MD Anderson Cancer Cente
Jun 10, 2024, 21:04 |
Blog
Marvin Delgado-Guay: Let's continue to grow the family
Suresh Reddy, Professor of the Department of Palliative Care and Rehabilitation Medicine, recently shared a…
Jun 10, 2024, 08:58 |
Career
Rachna Shroff: The greatest gift MD Anderson ever gave me!
Rachna Shroff shared a post on X: "We’re known for bringing the hype, but what…
May 21, 2024, 04:55 |
Drugs
Jayastu Senapati: Optimal use of Azacytidine Venetoclax in AML Patients in Indian Scenario
Jayastu Senapati, Assistant Professor of Leukemia at MD Anderson Cancer Center, shared a post on X:…
May 14, 2024, 15:36 |
Insight
Andy Hahn: Congrats to Ana Aparicio and team on this trial of 192 men with mCRPC
Andy Hahn, Genitourinary Medical Oncologist at MD Anderson Cancer Center, shared on X: “Congratulations to…
Apr 22, 2024, 18:54 |
Insight
Myeloma Paper of the Day, April 22nd, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
Apr 18, 2024, 17:32 |
Career
Jason Westin has been named Advocate of the Year by ASCO
ASCO recently announced their Advocate of the Year 2023 winner, stating: "ASCO members have many…
Apr 15, 2024, 16:24 |
Blog
Peter WT Pisters: Delighted to represent MD Anderson Cancer Center at this morning's American Association for Physician Leadership Annual Leadership Conference keynote
Peter WT Pisters, President of the University of Texas MD Anderson Cancer Center shared on…
Apr 15, 2024, 13:08 |
Blog
Matt Campbell: Greatly enjoyed taking part in the Translational and Basic Science section at UTCGW24
Matt Campbell, Genitourinary Medical Oncologist at UT MD Anderson Cancer Center, shared a post on…
All:
8
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube